Yield10 Bioscience (YTEN) Posts Earnings Results, Misses Estimates By $0.06 EPS

Yield10 Bioscience (NASDAQ:YTEN) released its earnings results on Thursday. The specialty chemicals company reported ($0.26) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.20) by ($0.06), Morningstar.com reports. The firm had revenue of $0.08 million during the quarter. Yield10 Bioscience had a negative net margin of 1,377.53% and a negative return on equity of 101.61%.

Shares of YTEN traded down $0.01 on Friday, reaching $1.44. The stock had a trading volume of 27,564 shares, compared to its average volume of 37,882. The stock has a market cap of $14.32 million, a PE ratio of -0.44 and a beta of 2.91. The company has a quick ratio of 6.82, a current ratio of 6.82 and a debt-to-equity ratio of 0.10. Yield10 Bioscience has a 12-month low of $1.12 and a 12-month high of $8.67.

An institutional investor recently raised its position in Yield10 Bioscience stock. Renaissance Technologies LLC increased its position in Yield10 Bioscience Inc (NASDAQ:YTEN) by 13.1% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 383,376 shares of the specialty chemicals company’s stock after purchasing an additional 44,300 shares during the quarter. Renaissance Technologies LLC owned approximately 3.84% of Yield10 Bioscience worth $541,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 10.63% of the company’s stock.

Separately, Maxim Group restated a “buy” rating and issued a $7.00 target price on shares of Yield10 Bioscience in a research note on Friday, September 21st.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by WKRB News and is the sole property of of WKRB News. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.wkrb13.com/2018/11/10/yield10-bioscience-yten-posts-earnings-results-misses-estimates-by-0-06-eps.html.

Yield10 Bioscience Company Profile

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.

Featured Article: What are the most popular ETFs

Earnings History for Yield10 Bioscience (NASDAQ:YTEN)

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply